Aamand R, Ho YL, Dalsgaard T, Roepstorff A, Lund TE. Dietary nitrate facilitates an acetazolamide-induced increase in cerebral blood flow during visual stimulation. J Appl Physiol 116: 267-273, 2014. First published December 12, 2013 doi:10.1152/japplphysiol.00797.2013The carbonic anhydrase (CA) inhibitor acetazolamide (AZ) is used routinely to estimate cerebrovascular reserve capacity in patients, as it reliably increases cerebral blood flow (CBF). However, the mechanism by which AZ accomplishes this CBF increase is not entirely understood. We recently discovered that CA can produce nitric oxide (NO) from nitrite, and that AZ enhances this NO production in vitro. In fact, this interaction between AZ and CA accounted for a large part of AZ's vasodilatory action, which fits well with the known vasodilatory potency of NO. The present study aimed to assess whether AZ acts similarly in vivo in the human cerebrovascular system. Hence, we increased or minimized the dietary intake of nitrate in 20 healthy male participants, showed them a full-field flickering dartboard, and measured their CBF response to this visual stimulus with arterial spin labeling. Doing so, we found a significant positive interaction between the dietary intake of nitrate and the CBF modulation afforded by AZ during visual stimulation. In addition, but contrary to studies conducted in elderly participants, we report no effect of nitrate intake on resting CBF in healthy human participants. The present study provides in vivo support for an enhancing effect of AZ on the NO production from nitrite catalyzed by CA in the cerebrovascular system. Furthermore, our results, in combination with the results of other groups, indicate that nitrate may have significant importance to vascular function when the cerebrovascular system is challenged by age or disease.nitrate; cerebral blood flow; nitric oxide; acetazolamide ACETAZOLAMIDE (AZ) IS WELL known to increase cerebral blood flow (CBF) and is used routinely to estimate cerebrovascular reserve capacity (CVRC) in patients (13, 32). However, the mechanism by which AZ accomplishes this CBF increase is not entirely understood (35). AZ is an inhibitor of the ubiquitous enzyme carbonic anhydrase (CA), which normally catalyzes the reversible hydration of CO 2 (CO 2 ϩ H 2 O ↔ H 2 CO 3 ↔ HCO 3 Ϫ ϩ H ϩ ). CA is thus an integral part of the system that rids the body of the CO 2 produced in tissues (26). For the same reason, CA also acts to equilibrate the pH transients occurring, e.g., upon metabolic activity. The effect of AZ is usually assumed to be linked to cerebral acidosis caused by an AZ-induced increase in the cerebral partial pressure of CO 2 (PCO 2 ) (5).We recently discovered that CA is also capable of catalyzing the conversion of the endogenous anion nitrite into nitric oxide (NO) (2), a potent vasodilator. In that study, we also attempted to block CA's catalyzation of the NO production by introducing the CA inhibitor AZ to the reaction. However, to our surprise, AZ markedly increased the production of NO ...